% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I1297540436&score_min=67
% 8 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2022-34807243,
  author  = {Salloway, S. and Chalkias, S. and Barkhof, F. and Burkett, P. and Barakos, J. and Purcell, D. and Suhy, J. and Forrestal, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4161},
  pmid    = {34807243},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4161}
}

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{rojas2021-33827960,
  author  = {Rojas, J. C. and Wang, P. and Staffaroni, A. M. and Heller, C. and Cobigo, Y. and Wolf, A. and Goh, S. M. and Ljubenkov, P. A. and others},
  title   = {{Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000011848},
  pmid    = {33827960},
  url     = {https://doi.org/10.1212/wnl.0000000000011848}
}

@article{mummery2023-37095250,
  author  = {Mummery, C. J. and Börjesson-Hanson, A. and Blackburn, D. J. and Vijverberg, E. G. B. and De Deyn, P. P. and Ducharme, S. and Jonsson, M. and Schneider, A. and Rinne, J. O. and Ludolph, A. C. and Bodenschatz, R. and Kordasiewicz, H. and others},
  title   = {{Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial}},
  journal = {Nature Medicine},
  year    = {2023},
  doi     = {10.1038/s41591-023-02326-3},
  pmid    = {37095250},
  url     = {https://doi.org/10.1038/s41591-023-02326-3}
}

@article{raghavan2020-32568366,
  author  = {Raghavan, N. S. and Dumitrescu, L. and Mormino, E. and Mahoney, E. R. and Lee, A. J. and Gao, Y. and Bilgel, M. and Goldstein, D. and others},
  title   = {{Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.1760},
  pmid    = {32568366},
  url     = {https://doi.org/10.1001/jamaneurol.2020.1760}
}

@article{petersen2026-41714746,
  author  = {Petersen, Kellen K and Milà-Alomà, Marta and Li, Yan and Du, Lianlian and Xiong, Chengjie and Tosun, Duygu and Saef, Benjamin and Saad, Ziad S and others},
  title   = {{Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks}},
  journal = {Nature medicine},
  year    = {2026},
  doi     = {10.1038/s41591-026-04206-y},
  pmid    = {41714746},
  url     = {https://doi.org/10.1038/s41591-026-04206-y}
}

@article{weiner2015-26073027,
  author  = {Weiner, M. W. and Veitch, D. P. and Aisen, P. S. and Beckett, L. A. and Cairns, N. J. and Cedarbaum, J. and Green, R. C. and Harvey, D. and others},
  title   = {{2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.11.001},
  pmid    = {26073027},
  url     = {https://doi.org/10.1016/j.jalz.2014.11.001}
}

@article{edwards2023-37902726,
  author  = {Edwards, A. L. and Collins, J. A. and Junge, C. and Kordasiewicz, H. and Mignon, L. and Wu, S. and Li, Y. and Lin, L. and others},
  title   = {{Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.3861},
  pmid    = {37902726},
  url     = {https://doi.org/10.1001/jamaneurol.2023.3861}
}